1. Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021;9:1511.
2. Griffiths C, Armstrong A, Gudjonsson J, Barker J. Psoriasis. Lancet. 2021;397:1301-15.
3. Torres T, Filipe P, Menezes Brandão F, Figueiredo A, Pinto Soares A, Sousa Basto A, et al. Epidemiology of psoriasis in Portugal: a population-based study. Acta Med Port. 2023 (in press). doi:https://doi.org/10.20344/amp.19048.
4. Moital I. Estudo PeSsOa - perfil clínico-epidemiológico e da qualidade de vida dos doentes com psoríase em Portugal. Lisboa. 2016. [cited 2022 Nov 27]. Available from: https://psoportugal.pt/wp-content/uploads/2020/04/Estudo-PeSsOa_suma%CC%81rio-executivo_resultados_v1.2.pdf.
5. Cai Q, Teeple A, Wu B, Muser E. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis. J Med Econ. 2019;22:1290-97.